Chenyi Pan

Chenyi Pan is a highly experienced scientist specializing in bioanalytical sciences, currently serving as a Principal Scientist at Alnylam Pharmaceuticals since June 2025. Previously, as a Senior Manager in Clinical Pharmacology at CRISPR Therapeutics, Chenyi Pan led bioanalytical activities for clinical development of CRISPR-edited therapies and managed vendor lifecycle processes to ensure data quality and compliance. Prior experience includes roles at Frontage Laboratories, where efforts were focused on assay development for biologics and gene therapies, as well as academic research at Georgia Institute of Technology, where innovative biosensor systems and gene editing techniques were developed. Chenyi Pan holds a Ph.D. in Biology from Georgia Institute of Technology and a Bachelor's Degree in Biological Sciences from Zhejiang University.